Siga Technologies (SIGA) Cash & Equivalents (2010 - 2025)
Siga Technologies (SIGA) reported Cash & Equivalents of $155.0 million for Q4 2025, little changed on a YoY basis from $155.4 million in Q4 2024, and down 9.88% quarter-over-quarter from $172.0 million in Q3 2025.
Siga Technologies (SIGA) Cash & Equivalents (2010 - 2025) Analysis & Trends
Siga Technologies has reported Cash & Equivalents for 16 years, with the latest figure at $155.0 million in Q4 2025.
- For the quarter ending Q4 2025, Cash & Equivalents changed 0.28% year-over-year to $155.0 million; the trailing twelve-month figure through Dec 2025 stood at $155.0 million (changed 0.28% YoY), and the FY2025 full-year result was $155.0 million, changed 0.28% from the prior year.
- Cash & Equivalents for Q4 2025 stood at $155.0 million, down from $172.0 million in the prior quarter.
- The five-year high for Cash & Equivalents was $182.5 million in Q2 2025, with the low at $71.1 million in Q3 2023.
- Historically, Cash & Equivalents has averaged $123.4 million across 5 years, with a median of $112.1 million in 2022.
- Annual changes were most pronounced in 2021 — Cash & Equivalents soared 85.59% — and 2023, when it tumbled 35.2%.
- Siga Technologies' Cash & Equivalents stood at $103.1 million in 2021, then slipped by 4.22% to $98.8 million in 2022, then jumped by 51.98% to $150.1 million in 2023, then climbed by 3.5% to $155.4 million in 2024, then declined by 0.28% to $155.0 million in 2025.
- The last three Cash & Equivalents figures came in at $155.0 million (Q4 2025), $172.0 million (Q3 2025), and $182.5 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 3.74 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 1.94 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 1.28 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 40.42 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 266.50 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 428.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 351.55 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 498.58 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 222.27 Mn |
| 10 | Siga Technologies | 310.79 Mn | 155.83 Mn | - | 154.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 154.97 Mn |
| Sep 30, 2025 | 171.96 Mn |
| Jun 30, 2025 | 182.46 Mn |
| Mar 31, 2025 | 162.27 Mn |
| Dec 31, 2024 | 155.40 Mn |
| Sep 30, 2024 | 99.27 Mn |
| Jun 30, 2024 | 106.95 Mn |
| Mar 31, 2024 | 143.87 Mn |
| Dec 31, 2023 | 150.15 Mn |
| Sep 30, 2023 | 71.11 Mn |
| Jun 30, 2023 | 76.21 Mn |
| Mar 31, 2023 | 115.68 Mn |
| Dec 31, 2022 | 98.79 Mn |
| Sep 30, 2022 | 109.75 Mn |
| Jun 30, 2022 | 114.53 Mn |
| Mar 31, 2022 | 153.26 Mn |
| Dec 31, 2021 | 103.14 Mn |
| Sep 30, 2021 | 92.82 Mn |
| Jun 30, 2021 | 98.49 Mn |
| Mar 31, 2021 | 106.53 Mn |